Growth pathways play key roles in longevity. The present study tested single-nucleotide polymorphisms (SNPs) in the connective tissue growth factor gene (CTGF) and the epidermal growth factor receptor gene (EGFR) for association with longevity. Comparison of allele and genotype frequencies of 12 CTGF SNPs and 41 EGFR SNPs between 440 American men of Japanese ancestry aged ≥95 years and 374 men of average life span revealed association with longevity at the p < .05 level for 2 SNPs in CTGF and 7 in EGFR. Two in CTGF and two in EGFR remained significant after Bonferroni correction. The SNPs of both CTGF and EGFR were in a haplotype block in each respective gene. Haplotype analysis confirmed the suggestive association found by χ 2 analysis. We noted an excess of heterozygotes among the longevity cases, consistent with heterozygote advantage in living to extreme old age. No associations of the most significant SNPs were observed in whites or Koreans.
target of rapamycin (mTOR), and genes in the signaling pathways of each gene (1, (3) (4) (5) . Furthermore, modulation of such genes alters life span (6) (7) (8) . These are among the range of biological pathways that form a signaling network, are sensitive to nutritional status, modulate growth, stress resistance, risk for age-related disease, and, ultimately, affect aging itself. A novel theory of aging that integrates these observations is the hyperfunction theory (9) . This theory posits that growth and reproductive processes that are important in early-life run unchecked in later life, resulting in higher risk for hypertrophic (eg, cardiovascular disease) and hyperplastic (eg, cancer) pathology. The genetic influences in such biological pathways have yet to be elucidated, but clearly genes within the insulin-signaling/insulin-like growth factor 1 pathway and the mTOR pathway fit this view of aging.
Our previous research on genes in growth pathways identified association of several common single-nucleotide polymorphisms (SNPs) in the human FoxO3 gene (FOXO3) with attainment of extreme old age in American men of Japanese ancestry (10) , but failed to identify associations of SNPs in other genes in growth pathways. In particular, no association was found for SNPs in FOXO1, SIRT1, ADIPOQ, COQ7 (10) , other insulin/insulin-like growth factor pathway genes (ATF4, CBL, CDKN2, EXO1, and JUN) (11) , and in the mTOR gene (MTOR) and genes in the mTOR pathway (RPTOR, RICTOR, and RPS6KA1) (12) . Nevertheless, transcriptional differences in mTOR pathway genes have been noted in longlived participants (13) . In mice, the mTOR pathway gene Ddit4 is overexpressed 33-fold in liver in response to caloric restriction (14) . Deletion of ribosomal protein S6 kinase 1 gene (Rps6ka1), a downstream gene in the mTOR signaling pathway, increases life span of female mice (15) . Based simply on the large number of genes differentially expressed in response to caloric restriction (14) , the number of potential candidate genes for longevity is considerable.
We hypothesize that SNPs in human genes that influence longevity and/or healthy aging do so by modulating their own expression, by responding differentially to factors induced by caloric restriction, and/or by affecting protein-protein interactions, among other mechanisms. Whereas involvement of growth hormone and insulin/ insulin-like growth factor and proteins in their respective signaling pathways is well known to affect life span, the role of other growth factors and growth factor receptor pathways is less well understood.
In the present study, we selected two growth factor genes that exhibit increased hepatic expression in response to caloric restriction in mice and that were in that study the only genes encoding proteins involved in growth-promoting pathways (14) . We genotyped SNPs in the human homolog of each-the human connective tissue growth factor gene (CTGF) and the epidermal growth factor receptor gene (EGFR; Supplementary Table S1)-testing for association with longevity (living to beyond 95 years of age) using a well-characterized population of American men of Japanese ancestry. The most significant SNPs were used for replication studies in Korean as well as in white American and German longevity cohorts.
Methods
The Methods section is available as a Supplementary File. Supplementary Table S2 shows characteristics of cases and controls. Many well-known risk factors were significantly lower in cases. Average year of birth for controls (1916.8) differed significantly from cases (1909.9), as did years of education (10.8 vs 9.9, respectively). Figure S1 (a) shows location on chromosome 6, together with "marker" numbers for each. Two SNPs, rs9399005 and rs7768619, remained significant after Bonferroni correction (see footnote in Table 1 ). Values for phenotypic variables as a function of genotype for the most significant SNP (rs9399005) are shown in Supplementary Table S3 (a: major allele homozygotes vs minor allele carriers; b: heterozygote vs homozygotes). The majority of the CTGF SNPs genotyped were on a segment of linkage disequilibrium spanning 8 kb ("Block 1"; Supplementary Figure S1 ). Supplementary Figure S1 (b) shows the haplotypes for this block. SNPs rs9399005 and rs7768619 were in a haplotype (TGAGTCC) of frequency 0.32. There was an overabundance of heterozygotes in the long-lived participants relative to the total population sample (Table 1(b); Supplementary Figure S2 ). Figure S3 (a) shows location on chromosome 7. Two of the seven SNPs remained significant after Bonferroni correction (see footnote in Table 2 ). Values for phenotypic variables as a function of genotype for the most statistically significant SNP (rs2075101) are shown in Supplementary Tables S4 (a: major allele homozygotes vs minor allele carriers; b: heterozygote vs homozygotes). The majority of the EGFR SNPs genotyped were on a segment of linkage disequilibrium spanning 5 kb ("Block 2"; Supplementary Figure S3 ). SNP rs1050171 was 1,028 bp away from rs7795743. Supplementary Figure S3 (b) shows the haplotypes for this block. The SNPs denoted by markers "10," "11," "13," "15," and "19" were in a "longevity" haplotype CAAGTTATGC of frequency of 0.076. There was an excess of long-lived participants who were heterozygous for these SNPs ( 
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Bioinformatic Analyses
The RegulomeDB database was found to contain 46 SNPs in CTGF that overlap with putative transcription factor binding sites and/ or chromatin modification (Supplementary Table S7 ). The GRASP database identified seven SNPs in CTGF from GWAS analyses to be associated with quantitative traits (Supplementary Table S8 ) and the FuncPred database led to identification of four CTGF SNPs with potential functions (Supplementary Table S9 ). Potential functional variants in CTGF identified by HaploReg, which uses GTEX data, are shown in Supplementary Table S10. For EGFR, RegulomeDB showed 100 SNPs that potentially overlap with transcription factor binding sites and/or chromatin modification (Supplementary Table S11 ) and the GRASP database search identified 16 EGFR SNPs from previous GWAS studies with potential significance (Supplementary Table S12 ). The FuncPred database identified 242 EGFR SNPs of potential significance (Supplementary  Table S13 ), and further information was retrieved from HaploReg (Supplementary Table S14 ).
These data may form the basis for future experiments to ascertain the molecular basis for the longevity associations suggested by our genetic data.
Replication Studies
In the Korean sample, there was no significant association of CTGF SNPs rs9399005 or rs7768619 with longevity (Supplementary Table S15(a)). In white Europeans in Germany, there was no significant association of SNPs rs9399005 in CTGF and SNP rs11771471 in EGFR with longevity (Supplementary Table S15(b)). In the U.S. cohorts of white male and female participants, there was no significant association of CTGF SNPs rs9399005 and rs7768619 or EGFR SNP rs13222385, rs1554718, rs7795728, rs7795743, rs845561, rs1050171, and rs2075101 with longevity (Supplementary Table S15(c)).
Discussion
The present study finds possible support for an influence of genetic variation in CTGF and EGFR on life span in Americans of Japanese ancestry. Association of SNPs in EGFR with life span was reported in a prior Korean longevity sample (16) . There was no association of CTGF SNPs with longevity in the current Korean sample. The latter contained far fewer participants than the number of long-lived Japanese participants or the prior Korean sample, so reduced statistical power might have been a factor. Another consideration might be that Japanese participants were males only, whereas all but five of the Korean long-lived participants were female, making a sex difference a possibility. In German and U.S. white participants, no associations with longevity were seen for SNPs in either CTGF or EGFR, suggesting either a racial difference or much weaker association of SNPs in each gene with longevity in whites than in our Japanese cohort.
Relevant Actions of CTGF and EGFR
CTGF is a cysteine-rich matricellular secreted protein that regulates diverse cellular functions intimately involved in proliferation and differentiation, particularly in chondrocytes and connective tissue where it is a master regulator of bone and cartilage. It contains an insulinlike growth factor binding protein domain and binds various growth factors (17) . CTGF is involved in establishing and maintaining the extracellular matrix (ECM) and plays important roles in cell adhesion, migration, proliferation, differentiation, angiogenesis, skeletal development, tissue wound repair, survival, senescence, and apoptosis (18) . EGFR and its ligands are cell signaling molecules involved in diverse cellular functions, including cell proliferation, differentiation, motility, survival, autophagy, senescence, and tissue development (19) . FoxO3, CTGF, and EGFR are each critical for the growth versus senescence dichotomy and play essential roles in stem cell preservation. It has been shown that the EGF pathway increases longevity and health span in gain-of-function studies on Caenorhabditis elegans (see review (20) ).
The ECM is composed of secreted molecules that provide structural and biochemical support to the surrounding cells and that are essential for growth, wound healing, and fibrosis. Overexpression of CTGF in fibroblasts promotes fibrosis in the dermis, kidney, and . lung. The stem cell niche, which harbors stem cells, is a dynamic, specialized microenvironment that provides extracellular cues to allow stem cell survival and to maintain a balance between selfrenewal and differentiation, as well as maintaining stem cell homoeostasis. The ECM sequesters a wide range of cellular growth factors and acts as a local store for these (21) . Changes in physiological conditions can trigger protease activities that cause local release of the growth factor stores. This allows the rapid and local growth factor-mediated activation of cellular functions without de novo protein synthesis. ECM cells cause regrowth and healing of tissue. In the case of injury repair and tissue engineering, the ECM serves two main purposes. First, it prevents the immune system from mounting a response to an injury by triggering inflammation and scar tissue formation. Second, it facilitates tissue repair, instead of scar tissue formation, by the surrounding cells. ECM proteins are commonly used in cell culture systems to maintain stem and precursor cells in an undifferentiated state during cell culture. They also function to induce differentiation of epithelial, endothelial, and smooth muscle cells in vitro.
Excess of Heterozygotes
We noted an excess of heterozygotes among the longevity cases in our study. HWE was within normal limits, meaning an absence of any significant stratification or errors in genotyping. The benefit of heterozygote advantage has long been recognized in animal populations. In humans, heterozygosity for genetic variants in hemoglobin (22) and glucose-6-phosphate dehydrogenase (23) confers an advantage in geographic regions in which the malaria parasite is prevalent. Heterozygous advantage is also apparent in genes associated with infection or response to infectious agents. These include the Mediterranean fever gene (MEFV), the gap junction beta-2 gene (GJB2) encoding connexin 26 (24) , the prion protein gene (PRNP) (25) , the steroid 21-hydroxylase gene (CYP21), mutations in which cause congenital adrenal hyperplasia (26) , the cystic fibrosis transmembrane conductance regulator (CFTR) (27) , phenylalanine hydroxylase (PAH), mutations of which cause phenylketonuria (28) , and the factor V gene (F5), mutations in which cause thrombophilia (29) . Resistance to infectious agents is thought to play a role when mutations are present in the heterozygote state, whereas homozygosity for each alternate allele is a disadvantage. There is also heterozygote advantage in the "I'm not dead yet" gene (Indy) that confers longevity in Drosophila (30) . Because the controls for our case-control study were men who lived to at least 70 years, but not more than 81 years, there may have been some selection against genes for conditions capable of causing death prior to age 70 years. It is possible that there is an early-life or mid-life selection against homozygotes, but a late-life selection for heterozygotes. There was no increase in incidence of cancer in the samples from Examination 4 (data not shown).
Previous Genetic Association Findings for CTGF and EGFR
The CTGF variant we used that did not show an association with longevity-rs6918698-has been reported to be associated with a number of fibrotic phenotypes, such as systemic sclerosis in a European population (31) . A polymorphism in the CTGF promoter has also been associated with systemic sclerosis in a Japanese population (32) . In primary pulmonary fibroblasts, minor allele homozygotes increase transcriptional activity, and this is associated with a reduction in binding of the transcription factor Sp3 (a repressor) to the minor allele variant (31 Notes: EGFR = epidermal growth factor receptor gene; MAF = minor allele frequency; SNP = single-nucleotide polymorphism.
*After Bonferroni correction for multiple testing (× 41), p values remained significant for EGFR SNPs rs2075101 and rs1050171: (a) p = .041 and p = .025, respectively, (allele data) and (b) p = .036 and p = .020 (genotype data), whereas all others became nonsignificant (p > .05). Table 2 .
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higher among carriers of hepatitis C virus with liver fibrosis when compared with those without this condition (33) . The CTGF SNP rs9402373 was associated with hepatic fibrosis in patients in China, Sudan, and Brazil infected with schistosomes (34) . The CTGF variant rs6918698 was associated with colon cancer (35) . This SNP was used in our study but was not associated with longevity. The CC minor allele homozygote of CTGF variant rs6918698 is located in the promoter at -945 and is a significant risk factor for the progression of hepatitis C virus-related chronic liver disease, including hepatocellular carcinoma (36) . The GG major allele homozygote of CTGF variant rs6918698 was associated with an older age of onset of Crohn's disease (37) . A meta-analysis found that CTGF rs6918698 CG heterozygotes and minor allele CC homozygotes had a greatly decreased susceptibility to systemic sclerosis in Asian (38) and French (39) populations. Major allele homozygotes (GG) of CTGF variant rs6918698 are associated with predisposition to albuminuria in diabetic participants (40) .
In the case of genetic variants of EGFR, association studies in lung, breast, oral, colorectal, gastrointestinal, brain, endometrial, and liver cancer have been conducted (see review (41)). A dinucleotide repeat polymorphism in intron 1 of EGFR is associated with EGFR protein levels (42, 43) and non-small cell lung carcinoma outcomes (44) . Polymorphisms in EGFR have been reported to be associated with acute coronary syndrome (45) , dilated cardiomyopathy (46) , asthma (47) , systemic lupus (48) , and rheumatoid arthritis (49) . Some of these are potentially life threatening, so could explain the associations we observed with life span. EGFR variation was previously found to be associated with longevity in nonagenarian Korean women but not men (16) . Further support for a role in longevity is the ability of royalactin to extend C. elegans life span through EGF signaling (50) .
Conclusion
The present study found multiple SNPs in CTGF and EGFR to exhibit weak associations with longevity in our cohort of American men of Japanese ancestry. Polymorphisms in these genes might have the potential to confer effects on life span, at least in this population. The findings raise the possibility of a role for genetic variation in CTGF and EGFR as part of the molecular genetic basis for attainment of extreme old age in Japanese participants. Studies in larger populations of Japanese and other racial groups may be warranted. If validated, further research will be needed to determine the mechanisms by which causative variants in CTGF and/or EGFR and their encoded proteins might mediate an effect on life span.
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